Pfizer Animal Health’s acquisition of Alpharma

Pfizer Poultry Health acquisition of Alpharma LLC as part of the company’s acquisition of King Pharmaceuticals has introduced a broader, diversified portfolio of products and services and a wider portfolio of products and services.

"The integration expands Pfizer Poultry Health's product portfolio and broadens the range of health care solutions we can offer our poultry customers. It allows us to enter new therapeutic fields and deliver increased expertise to poultry producers," said José Francisco Ortiz C, Vice President, Pfizer Poultry Health & New Established Brands.

With this acquisition, Pfizer Poultry Health gains a portfolio of medicated feed additives, water-soluble therapeutics and probiotics and also enters the poultry nutrition sector. Read more ...

This blog is written by Martin Little The Global Miller, published and supported by the GFMT Magazine from Perendale Publishers.